CG Oncology Statistics
NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
62.38-1.26 (-1.98%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CG Oncology by the numbers
CG Oncology has a market capitalization of $5.53 billion based on 88.64M shares outstanding. With trailing EPS of $-2.69, CG Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.5% below its 50-day average and 2.8% below its 200-day average.
Average daily trading volume is 899.28K shares, or about $56.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CGON valuation vs. peer median
| Metric | CGON | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.53B | $5.10B | +8% |
| Avg. volume | 899.28K | 1.57M | -43% |
Peer median across 8 companies: KOD, IOVA, SRRK, CRSP, IMVT, ADPT, RLAY, TARS.
Valuation
- Market cap
- $5.53B
- Price / sales (latest FY)
- 1,368.66
- EPS (TTM)
- $-2.69
- Shares outstanding
- 88.64M
Price and trading
- Previous close
- 63.64
- Open
- 62.68
- Day range
- 61.93 – 63.64
- 52-week range
- 35.80 – 80.97
- 52-week change
- +64.16%
- Beta
- —
- Volume
- 621.82K
- Average volume
- 899.28K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 5.53B
- Forward Pe
- -20.65
- Eps
- -2.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 80.97
- Week52 Low
- 35.80
- Avg Volume
- 899.28K
- Shares Outstanding
- 88.64M
- Ma50
- 73.78
- Ma200
- 64.19
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -22.96%
- Pct From52w Low
- 74.25%